HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human glutathion S-transferase A1 polymorphism and susceptibility to urothelial cancer in the Japanese population.

Abstract
GSTA1 has been reported to be most efficient in detoxifying N-acetoxy PhIP. In this study, 341 Japanese urothelial cancer patients and 457 healthy controls were compared for frequencies of GSTA1 genotype. We present the first evidence of an association between GSTA1*B (-567G, -69T, -52A) and urothelial cancer among never smokers. The frequency of GSTA1 *A/*B or *B/*B genotype was 24.3% in urothelial cancer cases, compared with 21.2% in the control groups (OR=1.22; 95%CI 0.87-1.72) after adjustment for age, gender and smoking status. But among never smokers, the GSTA1 *A/*B or *B/*B genotype was significantly higher in urothelial cancer cases (31.2%) compared with the controls (19.9%) (OR=1.73; 95%CI 1.01-2.97). This study suggests that exposure to food-derived PhIP could be one of the risk factors in the incidence of urothelial cancer in never smokers.
AuthorsYasuhiro Komiya, Hiromasa Tsukino, Hiroyuki Nakao, Yoshiki Kuroda, Hirohisa Imai, Takahiko Katoh
JournalCancer letters (Cancer Lett) Vol. 221 Issue 1 Pg. 55-9 (Apr 18 2005) ISSN: 0304-3835 [Print] Ireland
PMID15797627 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • GSTA1 protein, human
  • Glutathione Transferase
Topics
  • Aged
  • Asian People
  • Carrier Proteins (genetics)
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Glutathione Transferase (genetics)
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Risk Factors
  • Smoking (adverse effects)
  • Urologic Neoplasms (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: